BridgeBio have substantially boosted its course of a novel treatment for amyloid heart disease, leveraging the compound. Preliminary trial data reveals promising outcomes for patients suffering with the debilitating https://attrcm560318.csublogs.com/50086467/bridgebio-improves-attr-cm-therapy-using-the-drug